🟢 MBRX is trading 6.1% up today as shares extend recent clinical data momentum

MBRX is trading at $3.47 (up 6.1%) as the stock continues to build on recent clinical data momentum and broader strength in the biotech sector.

• The move follows a strong pre-market jump from the previous close of $3.27, despite a lack of fresh company-specific news this morning.
• Shares appear to be benefiting from sustained bullish sentiment and a carryover effect from prior positive clinical results.
• The upward move outpaces the broader market's mild gains, highlighting the stock's independent momentum.